Discovery of N-(1-Acryloylazetidin-3-yl)-2-(1H-indol-1-yl)acetamides as Covalent Inhibitors of KRASG12C.
ACS Med Chem Lett
; 10(9): 1302-1308, 2019 Sep 12.
Article
in En
| MEDLINE
| ID: mdl-31531201